Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IGMS | Common Stock | Award | $4.66K | +398 | +0.77% | $11.71 | 52K | May 15, 2023 | Direct | F1 |
transaction | IGMS | Common Stock | Sale | -$15.3K | -1.24K | -2.39% | $12.30 | 50.7K | May 23, 2023 | Direct | F2, F3 |
transaction | IGMS | Common Stock | Sale | -$195 | -15 | -0.03% | $13.01 | 50.7K | May 23, 2023 | Direct | F2, F4 |
Id | Content |
---|---|
F1 | The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
F2 | These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. |
F3 | This transaction was executed in multiple trades at prices ranging from $12.00 to $12.95. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
F4 | This transaction was executed in multiple trades at prices ranging from $13.00 to $13.02. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |